Log in

CVE:MJNCronos Group Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume1.39 million shs
Average Volume2.07 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada's Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc. and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals. Whistler Medical Marijuana is licensed to produce and sell medical marijuana, as well as cultivate cannabis oil. Hydropothecary is licensed to produce medical marijuana. Abcann Medicinals also has license to produce medical marijuana. With interest in five Licensed Producers and two LP applicants, it is focused on building brand portfolio providing patients with personalized care.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryCannabis
SectorN/A
CUSIPN/A
CIKN/A
Phone+1-416-5040004

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Receive MJN News and Ratings via Email

Sign-up to receive the latest news and ratings for MJN and its competitors with MarketBeat's FREE daily newsletter.

Cronos Group (CVE:MJN) Frequently Asked Questions

Has Cronos Group been receiving favorable news coverage?

Press coverage about MJN stock has trended very positive this week, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cronos Group earned a coverage optimism score of 4.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near term. View the latest news aboutCronos Group.

Who are some of Cronos Group's key competitors?

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Canopy Growth (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), OrganiGram (OGI), IMV (IMV), CanniMed (CMED), MedReleaf (LEAF) and Village Farms International (VFF).

Who are Cronos Group's key executives?

Cronos Group's management team includes the following people:
  • Michael Ryan Gorenstein, President, Chief Executive Officer, Vice Chairman of the Board, Corporate Secretary
  • William Lawrence Hilson, Chief Financial Officer
  • Jason Adler, Director
  • Ryan Roebuck, Director
  • James Rudyk, Director
  • Alan Mark Friedman, Independent Director (Age 45)
  • Michael Howard Krestell, Independent Director

What is Cronos Group's stock symbol?

Cronos Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MJN."

How do I buy shares of Cronos Group?

Shares of MJN and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Cronos Group's official website?

The official website for Cronos Group is thecronosgroup.com.

How can I contact Cronos Group?

Cronos Group's mailing address is 720 King St W Suite 320, TORONTO, ON M5V 2T3, Canada. The company can be reached via phone at +1-416-5040004.

This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.